- Home
- CLLS vs MRCC Comparison
CLLS vs MRCC Comparison
Compare CLLS & MRCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLLS
- MRCC
- Stock Information
- Founded
- CLLS 1999
- MRCC 2011
- Country
- CLLS France
- MRCC United States
- Employees
- CLLS N/A
- MRCC N/A
- Industry
- CLLS Biotechnology: Pharmaceutical Preparations
- MRCC Investment Managers
- Sector
- CLLS Health Care
- MRCC Finance
- Exchange
- CLLS Nasdaq
- MRCC Nasdaq
- Market Cap
- CLLS 148.1M
- MRCC 176.4M
- IPO Year
- CLLS 2007
- MRCC 2012
- Fundamental
- Price
- CLLS $1.24
- MRCC $7.80
- Analyst Decision
- CLLS Buy
- MRCC Hold
- Analyst Count
- CLLS 3
- MRCC 1
- Target Price
- CLLS $7.00
- MRCC $8.00
- AVG Volume (30 Days)
- CLLS 836.8K
- MRCC 80.3K
- Earning Date
- CLLS 03-13-2025
- MRCC 05-07-2025
- Dividend Yield
- CLLS N/A
- MRCC 12.85%
- EPS Growth
- CLLS N/A
- MRCC 2515.72
- EPS
- CLLS N/A
- MRCC 0.45
- Revenue
- CLLS $49,217,000.00
- MRCC $60,527,000.00
- Revenue This Year
- CLLS $1.26
- MRCC N/A
- Revenue Next Year
- CLLS N/A
- MRCC N/A
- P/E Ratio
- CLLS N/A
- MRCC $17.37
- Revenue Growth
- CLLS 435.38
- MRCC N/A
- 52 Week Low
- CLLS $1.14
- MRCC $7.01
- 52 Week High
- CLLS $3.38
- MRCC $8.85
- Technical
- Relative Strength Index (RSI)
- CLLS 38.55
- MRCC 40.54
- Support Level
- CLLS $1.28
- MRCC $7.70
- Resistance Level
- CLLS $1.35
- MRCC $7.89
- Average True Range (ATR)
- CLLS 0.07
- MRCC 0.17
- MACD
- CLLS 0.01
- MRCC -0.00
- Stochastic Oscillator
- CLLS 38.46
- MRCC 28.99
About CLLS Cellectis S.A.
Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC, product candidates in other therapeutic indications.
About MRCC Monroe Capital Corporation
Monroe Capital Corp is a speciality finance company focused on providing financing to lower middle-market companies, in the U.S. and Canada. The company provides customized financing solutions focused on senior, unitranche, and junior secured debt and unsecured subordinated debt and equity, including equity co-investments in preferred and common stock and warrants.